Abstract
There is a high rate of alcohol use disorders (AUDs) in the United States and this poses a substantial burden on the medical system due to health complications. Medications to treat AUDs have been proven to have efficacy in reducing the number of drinking days, amount of alcohol consumed at a time, and in achieving overall abstinence from alcohol.
Highlights
The estimated prevalence of alcohol use disorder (AUD) in the general population over a 12-month period is 8.46% [1]
alcohol abstinence medications (AAMs) utilization remains very low for the treatment of AUDs
Education about AUDs, the various treatments and their efficacy, the impact of under-treating, and reimbursement would improve the quality of care for this patient population and would help to reduce comorbidity and the financial burden associated with AUDs
Summary
The estimated prevalence of alcohol use disorder (AUD) in the general population over a 12-month period is 8.46% [1]. It has been estimated that 52% of the general population reports current use of alcohol and that 17.6 million Americans have an AUD [2]. The utilization of alcohol abstinence medications (AAMs) is limited. There is a high rate of alcohol use disorders (AUDs) in the United States and this poses a substantial burden on the medical system due to health complications. As well as other researchers, have shown that alcohol abstinence medications (AAMs) are underutilized. Its wide-spread utilization was compromised by the fact that patients could avoid side effects by not taking the medication. Studies have shown that patients taking disulfiram report fewer
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
